INTRODUCTION
Histaminergic neurons in the tuberomammilary nucleus (TMN), a region of the posterior hypothalamus, help sustain wakefulness (Anaclet et al., 2009; Haas et al., 2008; Lin et al., 1988 Lin et al., , 1989 Monnier et al., 1967; Nicholson et al., 1991; Parmentier et al., 2002 Parmentier et al., , 2009 Saper et al., 2010; Wada et al., 1991; Yu et al., 2014) . They are the sole source of neuronal histamine and send axons throughout the brain (Bayliss et al., 1990; Panula et al., 1984; Watanabe et al., 1983) . TMN neurons become active just after waking and fire at an average rate of about 5 Hz, and their activity is suppressed during sleep (Sakai et al., 2010; Saper et al., 2010; Takahashi et al., 2006) . Histamine modulates diverse circuitries (Ellender et al., 2011; Haas et al., 2008; Wada et al., 1991) . Histamine can suppress, for example, glutamate or GABA inputs to local circuits by activating hetero-H3 metabotropic receptors on terminals; it can also depolarize cells via H1 and H2 metabotropic receptors or cause phosphorylation of ion channels that influence firing rate (Atzori et al., 2000; Ellender et al., 2011) . These effects can occur in the same local circuitry. At the behavioral level, the net effects of histamine's actions on circuits are enhanced aspects of wakefulness such as cognition, locomotion, feeding, and motivation (Torrealba et al., 2012) .
Physiological investigations have focused on the histaminergic aspect of TMN neurons. But these neurons also contain glutamic acid decarboxylase (GAD) enzymes and GABA itself (Airaksinen et al., 1992; Senba et al., 1985; Takeda et al., 1984; Trottier et al., 2002; Vincent et al., 1983 ). GABA's presence in histaminergic neurons is conserved, from fish through to humans, suggesting a core function (Sundvik and Panula, 2012; Trottier et al., 2002) . It is not known what this function is, and there has been no demonstration that these cells actually release GABA. Optogenetic stimulation of histaminergic fibers in the ventral lateral preoptic (VLPO) area of the hypothalamus found that histamine release stimulated local GABAergic interneurons (Williams et al., 2014) , but provided no evidence of GABA release from the histamine fibers.
Varicosities on TMN axons broadcast histamine by volume transmission-histaminergic neurons rarely use synapses (Takagi et al., 1986) . So it is likely that if these same TMN axons do release GABA, then this particular source of GABA would also function, similar to histamine, in a paracrine manner that would principally affect extrasynaptic receptors. Because GABA is an electroneutral zwitterion at physiological pH, it has diminished interactions with the extracellular matrix. Thus GABA is well suited for diffusion over long distances (Roberts and Sherman, 1993) . Ambient (nonsynaptic) GABA produces sustained inhibitory currents by activating high-affinity extrasynaptic ionotropic GABA A receptors (Brickley et al., 1996; Brickley and Mody, 2012; Lee and Maguire, 2014) ; this is termed the tonic inhibitory conductance (G tonic ).
In this paper we start by showing that selective pharmacogenetic stimulation of histamine neurons enhances behavioral arousal. We then demonstrate that knocking down or removing vgat gene expression from histaminergic neurons increases locomotion, and causes a substantial increase in wakefulness during the night. Optogenetically stimulating histaminergic fibers in the neocortex and caudate-putamen increases G tonic onto pyramidal neurons and medium spiny cells, respectively. Eliminating vgat from histaminergic neurons selectively abolishes these evoked tonic inhibitory currents. Thus, during wakefulness, GABA can be deposited widely in neocortical and striatal circuitry by volume transmission. The GABA and histamine TMN components work together to regulate the amount of wakefulness. 
RESULTS

Histaminergic Neurons Stimulate Arousal but Are Also GABAergic
We first tested the excitatory nature of histaminergic neurons on behavior by selectively stimulating them pharmacogenetically in vivo with DREADD hM3Dq-mCherry receptors and clozapine-N-oxide (CNO) (Alexander et al., 2009; Krashes et al., 2011) . The hM3Dq receptor is an excitatory metabotropic receptor. Histaminergic neurons can be genetically targeted because of their unique expression of the histidine decarboxylase (hdc) gene, allowing the generation of HDC-Cre mice (Yu et al., 2014; Zecharia et al., 2012) . The TMN area of HDC-Cre mice was bilaterally transduced with AAVflex-hM3Dq-mCherry ( Figure 1A ) to produce HDC-hM3Dq mice. Intraperitoneal administration of CNO, but not saline, to these HDC-hM3Dq mice significantly increased their motor activity in an open area ( Figure 1B ) (saline, n = 4; CNO, n = 4, two-way ANOVA and post hoc Bonferroni, *p < 0.05; **p < 0.01; measurements taken 30 min post CNO or saline injection). In these mice, the hM3Dq-mCherry receptor was selectively expressed in most histaminergic neurons (348 mCherry-positive cells out of 405 HDC-positive cells were counted across three animals; 85% ± 3.5% of the HDC-neurons were mCherry positive) ( Figure 1C ). Using whole-cell recording in acute slices from the TMN area of HDC-hM3Dq mice (n = 4 mice), we demonstrated that CNO significantly (paired t test, p < 0.05) depolarized TMN neurons by $5 mV (n = 11 cells, control, À46 ± 3 mV; CNO, À41 ± 2 mV). This was sufficient to elicit action potential (AP) firing in silent cells (5 out of 11) or increase AP firing rate in spontaneously active cells ( Figure 1D ). Thus, selectively activating histaminergic neurons generated hyperlocomotion and behavioral arousal.
In spite of this excitatory effect on behavior, histaminergic TMN cells contain GABA and its synthetic enzyme GAD67 (gad1) (Airaksinen et al., 1992; Takeda et al., 1984; Vincent et al., 1983) . By immunocytochemistry, we found that a majority of HDC-positive neurons costained strongly with GAD67 antisera (1,399 GAD67-positive cells out of 1,720 HDC-positive cells were counted across three animals; 81% ± 10% of the HDC neurons were GAD67 positive; Figure 2A ). We corroborated this result genetically by crossing HDC-Cre mice with conditional rosa-lox-stop-lox-YFP mice (Srinivas et al., 2001) . In these crosses, 85% ± 5% (n = 3 mice) of YFP-positive neurons in the TMN also expressed GAD67 ( Figure 2B ). Conventionally, if histaminergic neurons were to release GABA, they should also express the vesicular GABA transporter (vgat, Slc32a1) gene. With the exception of midbrain dopamine neurons (Tritsch et al., 2012 (Tritsch et al., , 2014 , vGAT has so far proved essential for all neurons that release GABA (Tong et al., 2008; Wojcik et al., 2006) ; vgat expression, however, has not been demonstrated for HDC cells. Crossing vGAT-Cre mice (Vong et al., 2011) with those containing a rosa-lox-stop-lox-tdTomato allele (Madisen et al., 2010) gave extensive tdTomato/HDC soma costaining in the TMN ( Figure 2C ). Thus histaminergic neurons express the vgat gene and have the potential to package GABA into vesicles. animals. We therefore developed vgat-selective shRNA constructs to knock down vgat expression ( Figure 3 and see Figure S1 available online) . For this we placed putative vgat shRNA sequences into a microRNA gene, mir30, in the 3 0 untranslated region of a transcript that also encodes dsRed (Stegmeier et al., 2005) . These constructs were termed dsRed-shvgat (oligo1, oligo2, or oligo3) ( Figure 3A) . We tested how well these constructs could reduce vgat reporter gene expression in transfected HEK293 cells by cotransfecting dsRed-shvgat (oligo1, oligo2, or oligo3) with CMV-vGAT, respectively. Two shRNAs strongly knocked down vgat reporter gene expression in HEK cells (Figures 3B and 3C, p < 0.05, t test) . Before moving to the more challenging area of the TMN, we used a striatum-based motor assay to demonstrate that the constructs, delivered in AAVs, worked effectively in vivo ( Figure S1) Figures S1C and S1F ).
To knock down vgat expression selectively in histaminergic neurons, we placed the dsRed-shvgat and dsRed-scramble cassettes in reverse orientation between heterologous lox sites (a FLEX switch) ( Figure 3D ), so that expression could only be induced by CRE recombinase (Atasoy et al., 2008) . The AAVflex-dsRed-shvgat or AAV-flex-dsRed-scramble viruses were bilaterally injected into the TMN area of HDC-Cre mice (Figure 3D ). The groups of mice are referred to as HDC-vgat KD and HDC-scramble, respectively. We also injected AAV-Cre-2A-Venus and AAV-GFP into the TMN area of vgat lox/lox mice to produce TMN-Dvgat and TMN-GFP mice, respectively (Figure 3F) . In TMN-Dvgat mice, the injections covered the TMN area; 77% ± 2% of HDC-positive neurons expressed Cre-2A-Venus ( Figure S2 ). In the TMN, all of the GAD67-positive neurons also contained HDC ( Figure 2A ). These TMN-Dvgat mice formed an approximate comparison for the HDC-vgat KD mice, with the caveat that some GABAergic cells in the TMN area in addition to the histaminergic cells could be affected. We tested the vgat gene expression levels in the TMN area of HDC-vgat KD and TMN-Dvgat mice by both qPCR on tissue punches and also single-cell qPCR from identified neurons in acute brain slices prepared from the TMN area ( Figure S3 ). The tissue-punch analysis showed that in both TMN-Dvgat and HDC-vgat KD mice, vgat mRNA levels in the TMN were significantly decreased compared with those in TMN-GFP or HDC-scramble mice (TMN-GFP, 1 ± 0.06 versus TMN-Dvgat, 0.5 ± 0.06, t test, **p < 0.01; HDC- Figure S4 ).
HDC-vgat KD and TMN-Dvgat Mice Are Hyperactive
We first quantified the general activity of the mice. In an open field assay, HDC-vgat KD mice ran significantly further and had higher instantaneous speeds than the HDC-scramble controls, maintaining a stable and high activity for the 30 min duration of the test ( Figure 3E ; HDC-scramble, n = 7; HDC-vgat KD, n = 8, two-way ANOVA and post hoc Bonferroni, *p < 0.05; **p < 0.01). Similarly, the TMN-Dvgat mice were continuously more active compared with TMN-GFP control mice ( Figure 3G ; TMN-GFP, n = 10; TMN-Dvgat, n = 6, two-way ANOVA and post hoc Bonferroni, **p < 0.01; ***p < 0.001). In fact, the activity of the TMN-Dvgat mice, as measured by instantaneous speed and distance covered, tended to increase toward the end of the experiment ( Figure 3G ). HDC-vgat KD mice ( Figure 4B ). In the day, both the HDC-vgat KD and HDC-scramble mice showed a similar sleep-wake patternwith the same amount of NREM sleep and wake ( Figures 4A, 4B , and S5B; wake, HDC-scramble (n = 6), 243 ± 10 min versus HDC-vgat KD (n = 6), 252 ± 18 min, t test, p > 0.05; NREM, HDC-scramble (n = 6), 425 ± 10 min versus HDC-vgat KD (n = 6), 409 ± 12 min, t test, p > 0.05). Similar to HDC-vgat KD mice, TMN-Dvgat mice had a strong ''sustained wakefulness'' phenotype confined to the night (Figures 4D , 4E, and S5C). Compared with the TMN-GFP controls (n = 5), TMN-Dvgat (n = 7) animals were awake nearly the whole night (TMN-GFP, 411 ± 9 min versus TMN-Dvgat, 586 ± 27 min, t test, ***p < 0.001). Conversely, these TMN-Dvgat mice exhibited little NREM sleep during the dark period (Figures 4E  and S5C ; TMN-GFP, 258 ± 12 min versus TMN-Dvgat, 118 ± 25 min, t test, **p < 0.01). Their amount of REM sleep was also decreased (TMN-GFP, 48 ± 9 min versus TMN-Dvgat, 13 ± 3 min, t test, **p < 0.01). Similar to the HDC-vgat KD mice, selectively during the night, TMN-Dvgat mice had a strong increase of their maximum q power frequency ( Figure 4F ). Thus both the HDC-vgat KD and TMN-Dvgat mice slept less. Their loss of sleep during the dark phase was not balanced by a corresponding increase in sleep duration during the day (two-way ANOVA and post hoc Bonferroni, ***p < 0.001).
HDC-vgat KD and TMN-Dvgat
After Sleep Deprivation, HDC-vgat KD and TMN-Dvgat Mice Still Sleep Less Than Control Mice, Maintaining Their Hyperactive State Given the lack of sleep displayed by the HDC-vgat KD and TMNDvgat mice during a typical 24 hr cycle, we investigated how they behaved after sleep deprivation. Compared with control mice, would they demonstrate more recovery sleep to compensate for general lack of sleep during the normal sleep-wake cycle? Mice were sleep deprived for 5 hr during the beginning of the day by presenting them with novel objects. After sleep deprivation, mice were allowed recovery sleep in their home cages (Figure S6) . Compared with the control mice, HDC-vgat KD mice had less NREM recovery sleep ( Figures S6A and S6B ), but the rate at which they reaccumulated their lost NREM sleep ($12.5 extra minutes NREM sleep recovered/hour) was similar to controls ( Figure S6C ). TMN-Dvgat mice behaved more extremely ( Figures  S6D and S6E) . After sleep deprivation they were awake longer than control sleep-deprived mice and some 16 hr after sleep deprivation were spending most of their time awake ( Figure S6E ). However, as for the TMN-Dvgat mice, the rate at which they reaccumulated their lost NREM sleep ($12 extra minutes NREM sleep recovered/hour) was similar to controls ( Figure S6F ). Thus HDC-vgat KD and TMN-Dvgat mice sleep less than control mice, maintaining their hyperactive state even after sleep deprivation.
Histaminergic Axons in Neocortex and Striatum Release Paracrine GABA Histamine neurons can globally coordinate behavioral states because their axons spread and diverge throughout the brain (Panula et al., 1989; Takagi et al., 1986; Wada et al., 1991) . Can the axonal projections of histaminergic neurons release GABA, and does this release require vGAT? The behavioral results with HDC-vgat KD and TMN-Dvgat mice imply that this is the case. We addressed this directly using optogenetic stimulation in two types of mice: HDC-Channel-Rhodopsin(ChR) mice and TMN-Dvgat/HDC-ChR mice. To make HDC-ChR mice, the TMN area of HDC-Cre mice was bilaterally injected with AAVflex-ChR2H134R-EYFP (Figures 5A and 5B) . A TMN acute slice from HDC-ChR mice with ChR-EYFP primary fluorescence is shown in Figure 5B . The ChR-EYFP fusion protein was enriched in the membrane of HDC-neurons, including their axons ( Figures  5B and 5C ). Brief 1 ms stimuli were delivered to the LED every 200 ms, resulting in a 460 nm 0.1 mW/mm 2 peak light pulse that decayed with a time course of 10 msec. A continuous 5 Hz protocol was delivered for 3 min to HDC-ChR-EYFP-positive neurons in acute TMN slices ( Figure 5D ). This ChR stimulation protocol was capable of entraining action potential firing at 5 Hz ( Figure 5E ), corresponding to wake-active firing rates of TMN neurons (Takahashi et al., 2006) . The ChR-EYFP fusion protein is an excellent substrate for anterograde axonal transport (Petreanu et al., 2007; Tye and Deisseroth, 2012) . EYFP-positive fibers, marking the presence of ChR, were present in both the caudate-putamen ( Figures 5F and 5G ) and all neocortical areas examined e.g., sensory, motor, and visual neocortex (Figures 5H We carried out functional circuit mapping by light-stimulating the ChR-EYFP labeled fibers in the neocortex ( Figure 6C ) and caudate-putamen ( Figure 6J ) prepared from TMN-Dvgat/HDCChR and HDC-ChR mice. Stimulation of HDC-ChR neocortical slices with brief light pulses delivered at 5 Hz generated slow and sustained increases in the holding current recorded, in whole-cell mode, from pyramidal cells ( Figure 6D ). This current resembled the G tonic produced by activation of extrasynaptic GABA A receptors (Brickley et al., 1996; Brickley and Mody, 2012; Bright et al., 2007; Wisden et al., 2002) . On average, G tonic significantly increased by 1.1 ± 0.3 nS (paired t test, p < 0.01; n = 8) in the HDC-ChR slices ( Figure 6E ). In the example shown ( Figure 6D) , the enhancement of G tonic was apparent after a few minutes of 5 Hz continuous optical stimulation, consistent with GABA diffusing to its target receptors from distant release sites (i.e., a paracrine action). To determine whether the GABA was being released directly from HDC terminals or if this required an interneuron intermediate, we repeated these experiments in the presence of TTX (1 mM) and 4-AP (100 mM) (Root et al., 2014) . A robust increase in G tonic was observed, and on average it significantly increased by 0.5 ± 0.1 nS (paired t test, p < 0.01; n = 9) in the HDC-ChR slices ( Figure 6F ). In contrast, there was no increase in G tonic in TMN-Dvgat/HDC-ChR slices following 5 Hz light stimulation ( Figure 6G ). On average G tonic was slightly reduced by À0.2 ± 0.1 nS (n = 9) in the TMN-Dvgat/HDC-ChR mice (paired t test, p = 0.225, n = 9; Figure 6H ). This suggests that vesicular GABA was being directly released from the histaminergic fibers using GABAergic (vGAT-dependent) vesicles to cause the increase in G tonic . The results also imply that the G tonic is not caused by activating any putative histamine-gated chloride channels (Fleck et al., 2012) . We next confirmed, independently of the HDC-specific vgat knockouts, that histamine release was not responsible for stimulating GABAergic interneurons to release GABA. We repeated the 5 Hz light stimulation of HDC-ChR fibers in the presence of the H1 receptor antagonist pyrilamine (20 mM) and the H2 receptor antagonist ranitidine (5 mM). A significant increase in G tonic (0.6 ± 0.2 nS, n = 11; paired t test, p < 0.05) still occurred (Figure 6I) , and as before, the increase was delayed after the onset of light stimulation. Applying H1/H2 receptor antagonists further suggested that there was no intermediary GABAergic interneuron involved that first required excitation by histamine, and which then released GABA to increase G tonic . Instead, GABA release in the neocortex from TMN axons was vGAT dependent.
ChR-EYFP-positive fibers were also present in the caudate putamen of HDC-ChR mice ( Figure 6J ). During 5 Hz light stimulation, there was a gradual increase in G tonic (1.9 ± 0.6 nS, n = 7; paired t test, p < 0.05) onto medium spiny neurons ( Figure 6K ). When the GABA A receptor antagonist gabazine (100 mM) was present during the stimulation, there was no increase in G tonic ; in fact, on average it decreased by À0.8 ± 0.5 nS (n = 6) ( Figure 6L ).
GABA Released from Histaminergic Axons Does Not Increase Phasic Inhibition, but Histamine Increases Synaptic Drive
We examined if GABA release from ''GABA-histaminergic'' axons in neocortex of HDC-ChR mice increased phasic (synaptic) GABA A receptor activation, in addition to its ability to raise G tonic . The timing of sPSCs was analyzed relative to the LED trigger ( Figure 7A) . By cross-correlation analysis, sPSCs were not phase locked with ChR stimulation ( Figure 7B ) (n = 9 recordings from four HDC-ChR mice). However, the sPSC frequency significantly increased in these neocortical slices from 6.4 ± 1.7 Hz (n = 9) to 9.5 ± 2.2 Hz (paired t test, p < 0.05). This increase in asynchronous sPSC frequency was not observed when these experiments were repeated in the presence of TTX/4-AP (Figure 7C) , although G tonic did significantly increase (see Figure 6F) . A similar increase in sPSC frequency was observed in the TMNDvgat/HDC-ChR mice, where the sPSC frequency increased from 8.7 ± 2.8 Hz (n = 9) to 15.6 ± 3.3 Hz (paired t test, p < 0.05). However, in these mice there was no increase in G tonic (see Figure 6H ). Does this light-evoked increase in sPSC rate depend on histamine release? In the presence of the H1 receptor antagonist pyrilamine (20 mM) and the H2 receptor antagonist ranitidine (5 mM), the ChR-stimulated increase in the rate of asynchronous sPSCs was blocked at the start and at the end of stimulation ( Figure 7D ; 23.9 ± 6.0 Hz [start] to 21.9 ± 5.4 Hz [end]; n = 11, paired t test, p = 0.3). For neocortical layer neurons, these data highlight the independent nature of the two signals from histaminergic-GABA axons originating from the TMN: an increased synaptic drive generated by histamine release and an increased G tonic generated by GABA release.
DISCUSSION
Histamine neurons form a globally projecting hub that integrates brain functions associated with wakefulness (Wada et al., 1991) . Starting in the TMN, histaminergic axons course large distances throughout the brain, generating extrasynaptic pools of transmitter. We showed that selective pharmacogenetic stimulation of these histamine neurons in vivo behaviorally excites the animals, as would be expected (Haas et al., 2008; Lin et al., 1988; Monnier et al., 1967; Nicholson et al., 1991) . But we also established that histaminergic neurons use vGAT to release GABA. Similar to histamine, the GABA released from histaminergic neurons functions in a paracrine manner, which would make these neurons an unexpected source of GABAergic volume transmission in the neocortex and striatum. As part of their integrative role in specifying behavioral state, we expect that these hypothalamic TMN ''GABA-histamine'' neurons will contribute to tonic inhibition of many neural circuits simultaneously. Mice whose GABA-histamine neurons cannot release GABA are hyperactive, and they sleep less and do not catch up on this lost sleep. The ''sleepless phenotype'' manifests during the night. Their behavior might be described as a form of mania (Kirshenbaum et al., 2011) , which in humans would be considered as part of a bipolar disorder. Neurons often corelease small molecules and peptides (Adamantidis, 2015; Klausberger and Somogyi, 2008; Schö ne and Burdakov, 2012; Tong et al., 2008; van den Pol, 2012) . ''Orexinergic'' neurons, for example, in the lateral hypothalamus corelease glutamate and orexin onto histaminergic neurons in the TMN (Schö ne et al., 2014) . The different time course of the excitatory actions of the two transmitters (glutamate, fast synaptic excitation; orexin, slow and sustained excitation) allows them to signal different aspects of ''metabolic integration'' (Schö ne et al., 2014) . In addition to peptides, some neurons release several small molecule transmitters simultaneously, sometimes of the same functional type, e.g., GABA-glycine (Jonas et al., 1998) , but often of functionally antagonist pairings, for example, GABA-glutamate, or GABA-acetylcholine or GABA-dopamine (Hnasko and Edwards, 2012; Vaaga et al., 2014) . In contrast to our findings on GABA-histamine neurons, other investigations into GABA cotransmission or corelease, including cotransmission with peptides, found only fast monosynaptic responses generated by the GABA component (Jego et al., 2013; Root et al., 2014; Shabel et al., 2014; Tong et al., 2008; Tritsch et al., 2012) . It might be expected that midbrain dopamine and histamine networks function similarly with respect to GABA release, but they do not. GABA is not synthesized in the dopamine neurons themselves-unlike the histamine neurons, they do not express the gad1 or gad2 genes-but GABA is instead scavenged into dopaminergic terminals by the transporters mGAT1 and mGAT4; it is hypothesized that GABA is then transported into dopamine vesicles by the monoamine transporter VMAT2 (Tritsch et al., 2012 (Tritsch et al., , 2014 . For histamine neurons, vgat knockout removes GABA release; the VMAT2 in histamine neurons does not substitute for vGAT. In cultured TMN neurons from embryos, GABA is in putative vesicles distinct from histaminergic ones, suggesting cotransmission rather than corelease (Kukko-Lukjanov and Panula, 2003) .
There is an intriguing potential for synergy directly at the receptor level between histamine and GABA. At (high) concentrations of around 1 mM, histamine is an effective positive allosteric modulator of a4 subunit-containing GABA A receptors (Bianchi et al., 2011) , which are the type of GABA A receptors often associated with extrasynaptic activation (Brickley and Mody, 2012) .
However, when we removed vgat from histamine (HDC-ChR) axons, this abolished the light-evoked increase in tonic inhibition on layer IV pyramidal neurons, suggesting that the histamine released was not sufficient to activate any a4 subunit-containing GABA A receptors that might have been present. Similarly, the vgat deletion experiment also ruled out that the increase in G tonic was due to activating (speculative) histamine-gated chloride channels (Fleck et al., 2012) . In the absence of vGAT, light triggered a general increase in synaptic drive onto pyramidal neurons, which was blocked by H1 and H2 receptor antagonists. This effect of histamine is likely to reflect the engagement of multiple changes in the inputs impinging onto pyramidal neurons, as described for striatal neurons (Ellender et al., 2011) . As the histamine system innervates most of the brain, further studies will be required to see if GABA is coreleased in other areas. In the ventral lateral preoptic hypothalamus, histamine axons do not release GABA when stimulated optogentically, but instead activate GABA interneurons by histamine release (Williams et al., 2014) . By contrast, our experiments using TTX in the neocortex suggest that in this brain region no intermediary interneurons convey TMN axon-evoked GABA release. About 20% of histamine neurons in the TMN only contain histamine (Figure 2A ), and these could be the ones that innervate VLPO.
The ''GABA-histamine'' TMN neurons only fire during wakefulness, so GABA will be released from their axons into the neocortex and striatum during the wake state. The paracrine nature of the GABA signal explains the lack of any phasic synaptic inhibition associated with GABA release from the histamine axons. Why would GABA-histamine neurons use contradictory ''stop-go'' signals? One reason could be to stop networks getting too excited by histamine: the HDC-vgat KD and TMN-Dvgat mice are more active and sleep less because the histaminergic system is overactive. The function of sleep is unknown, but an overactive histamine system, resulting in less sleep, may damage health and cause mania. GABA release from histamine neurons could keep the animal in the ''optimal arousal zone.'' A second reason could be related to the fact that in the awake neocortex, inhibition enhances processing (Haider et al., 2013) . Indeed, the wake-active GABAergic volume transmission generated by TMN neurons may sharpen cognitive responses, and so GABA could work together with histamine to enhance wakefulness. Increased ambient GABA levels will generate greater G tonic , which by speeding up the (K and L) Scatterplots for all recordings made from medium spiny neurons in the HDC-ChR mice in control conditions and with the GABA A receptor antagonist gabazine (10 mM). G tonic increased by 1.9 ± 0.6 nS (paired t test, p < 0.05; n = 7) in control conditions and decreased by À0.8 ± 0.5 nS in the presence of gabazine (paired t test, p = 0.3; n = 6).
membrane time constant will increase the requirement for EPSP-spike precision, and constrain coincidence detection so that only closely timed inputs trigger action potentials (Brickley and Mody, 2012; Bright et al., 2007; Duguid et al., 2012; Hamann et al., 2002; Wlodarczyk et al., 2013) . The long distances traversed by the GABA-histamine axons mean that extrasynaptic inhibition could be coordinated by the TMN over large cortical areas.
In conclusion, we think it is no longer correct to refer to TMN neurons as ''histaminergic'': the GABA arm of their activity is so striking that they might be referred to as ''GABA-histamine'' neurons. We have demonstrated that the wide-ranging GABAhistamine axons of the hypothalamic TMN broadcast dual inhib- In HDC-ChR mice the sPSC frequency significantly increased from 6.4 ± 1.7 Hz (n = 9) to 9.5 ± 2.2 Hz (paired t test, p < 0.05). In TMN-Dvgat/HDC mice, a similar increase in sPSC frequency was observed from 8.7 ± 2.8 Hz (n = 9) to 15.6 ± 3.3 Hz (paired t test, p < 0.05). With the H1 receptor antagonist pyrilamine (20 mM) and the H2 receptor antagonist ranitidine (5 mM), the ChRstimulated increase in the rate of asynchronous sPSCs was 23.9 ± 6.0 Hz at the start and 21.9 ± 5.4 Hz at the end of stimulation (n = 11, paired t test, p = 0.3).
itory-excitatory signals in the neocortex: an increased G tonic generated by GABA release, and an increased synaptic drive generated by histamine. The two components may work together to regulate the amount of wakefulness. If this balance of GABA-histamine cotransmission changes unfavorably, mania-like behaviors could emerge.
EXPERIMENTAL PROCEDURES Animals
All experiments were performed in accordance with the UK Home Office Animal Procedures Act (1986); all procedures were approved by the Imperial College Ethical Review Committee. The following strains of mice were used: HDC-Cre (129SVJ and C57BL/6J) (Zecharia et al., 2012) (Madisen et al., 2010) . See Supplemental Information for genotyping.
AAV Transgene Plasmids
Plasmid pAAV-iCre-2A-Venus was provided by Thomas Kuner (Abraham et al., 2010) . Plasmid pAAV-GFP was a gift from John T. Gray (Addgene plasmid 32396). Plasmid pAAV-EF1a-flex-ChR2H134R-EYFP was a gift from Karl Deisseroth (Addgene plasmid 20298). The H134R mutation enhances light-evoked ChR currents and reduces spike-frequency adaptation (Nagel et al., 2005; Pulver et al., 2009) . Plasmid pAAV-hSyn-flex-hM3Dq-mCherry was a gift from Bryan L. Roth (Addgene plasmid 44361) (Krashes et al., 2011) . The pPRIME system, cloned into AAV transgenes, was used to generate shRNAs in vivo (Stegmeier et al., 2005) . See Supplemental Information for shRNA sequences.
Adeno-Associated Virus Preparation and Stereotaxic Injections
To produce adeno-associated virus (AAV), the adenovirus helper plasmid pFD6, the AAV helper plasmids pH21 (AAV1) and pRVI (AAV2), and the pAAV transgene plasmids were cotransfected into HEK293 cells and the subsequent AAV particles harvested on heparin columns, as described previously (Klugmann et al., 2005) . To deliver the AAV into the brain, stereotaxic injections were performed using an Angle Two apparatus (Leica) linked to a digital brain atlas (Leica Biosystems Richmond, Inc.). Before injection, 1 ml AAV virus was mixed with 1 ml 20% mannitol (MERCK K93152782 111). The virus and mannitol mixture were injected into a pulled-glass pipette (Warner Instruments; OD = 1.00 mm, ID = 0.78 mm, length = 7.5 cm). Virus was injected at a speed of 25 nl/min. Virus (1 ml) was bilaterally injected into the brain, 0.5 ml for each side. For TMN, the injection coordinates were as follows: ML (À0.92 mm), AP (À2.70 mm), DV (À5.34 mm); ML (0.92 mm), AP (À2.70 mm), and DV (À5.34 mm). For unilateral injections, the injection coordinates were as follows: CPu, ML (À2.10 mm), AP (0.50 mm), and DV (À3.66 mm).
Histamine Measurements
Neocortex or striatum was collected and homogenized with 10 ml of 0.2 M perchloric acid per mg tissue and centrifuged at 10,000 rpm for 5 min at 4 C. The supernatants were collected and neutralized with an equal volume of 1 M potassium borate buffer. Brain histamine levels were determined with an ELISA kit (Beckman Coulter Co. number IM2562).
qPCR on Tissue Punches and Single-Cell qPCR Total RNA from tissue punches was extracted using Trizol (Invitrogen). Reverse transcription and PCR were performed using a TaqMan RNA-to-Ct 1-Step Kit (Life Technologies, 4392653) and an Applied Biosystems machine (Foster City, USA). Acute slices of the TMN area were made (see ''Electrophysiology''). AAV-transduced neurons were identified by fluorescence. After patching and recording (see ''Electrophysiology''), we used the Single-Cellto-CT Kit (Ambion). The content of the neuron was aspirated into the recording pipette and expelled into cell lysis/DNase I solution. Reverse transcription and cDNA preamplification were performed according to the kit protocol. qPCR was performed using the TaqMan Gene Expression Assay system. The TaqMan assay probes were designed and purchased from Invitrogen (UK): mvgat, Mm00494138_m1; m18srRNA, Mm03928990_g1; and mhdc, Mm00456104_m1.
EEG Analysis and Sleep-Wake Behavior EEG and EMG signals were recorded using Neurologger 2A devices (Anisimov et al., 2014; Yu et al., 2014) . The sleep state (wake, W; non-rapid eye movement, NREM; rapid eye movement, REM; doubt, D) was scored manually. See Supplemental Information for details. The sleep deprivation procedure, with presentation of novel objects, was performed as described (Yu et al., 2014) .
General Behavioral Activity: Open Field Assay
All experiments were performed during ''lights off'' (active phase). The locomotion activity was detected in an activity test chamber with infrared sensors (Med Associates, Inc). The ''instantaneous speed'' was calculated as the distance traveled divided by the time spent moving (but not including the time the mice spent in the stationary state). For the DREADD experiments, clozapine-N-oxide (C0832, Sigma-Aldrich, dissolved in saline, 5 mg/kg) or saline was administered i.p. 30 min before the start of the behavioral observations.
Electrophysiology Acute brain slices were prepared as described in Supplemental Information.
For optogenetic experiments, a 470 nm collimated LED (M470L3-C1, Thorlabs) was used to illuminate the slice through the objective lens, and currentclamp recordings were first made from histaminergic neurons to confirm ChR2 expression. Subsequent voltage-clamp experiments in neocortex and stratum were used for cross-correlation analysis of synaptic events using a 100 ms sliding window before and after each LED pulse. Changes in the tonic GABA A receptor-meditated conductance (G tonic ) were calculated from the average holding current.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article at http://dx.doi.org/10.1016/j. neuron.2015.06.003.
